Tuesday, March 31, 2015 4:54:34 PM
The abuser might prefer the ER opioid because bigger dose gives bigger high with less filler material to snort/inject, but as the chart below shows, ER opioids are but a drop in the giant bucket of IR opioids.
http://www.chronicpainperspectives.com/articles/feature-article/article/risk-evaluation-and-mitigation-strategies-rems-red-tape-or-a-remedy-for-opioid-abuse/8dd36b8e70b1db8988b98310efa863c9.html
According to my references, OxyIR comes as 5mg, 10mg, 15mg, and even 30mg, so this could very well be plain old OxyIR. The reason I believe this is an intermediate time-release opioid and not an immediate-release (oxyIR) is because 15mg would be far too sedating in an opioid-naive patient (especially 3 doses in 12 hours), and the study's exclusion criteria clearly excludes anyone with any concurrent opioid use (#21) or oxycodone exposure within 30 days (#26).
In summary, in my opinion, Elite is testing an intermediate-release ADT-oxycodone product which would be dosed at 6-8 hour interval instead of 4-6 hours for oxyIR or 12 hours for OxyContin. As far as I can tell, there is no direct comparator to this product, which may be why the efficacy trial is needed in the first place.
Why do I think this is a big deal? See the chart above for the number of IR prescriptions vs. ER prescriptions. What the intermediate-release oxy will do is the straddle the line between both. Okay to use on an as needed (PRN) basis for acute/temporary problem, but also okay to use on a scheduled basis for longer term pain issues. Also, okay to use scheduled every 8 hours with an extra as needed dose for breakthrough pain. As I said earlier, a GAME CHANGER. A new, novel drug that can be used as both an IR and ER.
Oh, Nasrat... my, my, my...
BTW and FYI, "parachuting" as mentioned above is a method of oral drug abuse in which the tablet(s) are crushed, wrapped in tissue, and swallowed. This allows for rapid G.I. absorption and therefore approximates the rush of snorting.
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2024 08:30:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 09:16:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:05:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM